Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gillard

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Chemical Society|October 15, 2010
Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5BSteven R LaPlante, James R Gillard, Araz Jakalian, et al.
The American Journal of Physiology|March 10, 1999
Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidenceA M Khan, M C Currás, J Dao, et al.
Toxicology and Applied Pharmacology|August 9, 2011
Altered cardiovascular reactivity and osmoregulation during hyperosmotic stress in adult rats developmentally exposed to polybrominated diphenyl ethers (PBDEs)Ashini Shah, Cary G Coburn, Abena Watson-Siriboe, et al.
Endocrinology|November 12, 2005
A novel role for endogenous pituitary adenylate cyclase activating polypeptide in the magnocellular neuroendocrine systemE R Gillard, M León-Olea, S Mucio-Ramírez, et al.
Journal of Medicinal Chemistry|October 29, 2013
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127)Steven R LaPlante, Michael Bös, Christian Brochu, et al.
Journal of Medicinal Chemistry|January 23, 2004
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activityBenoit M Kenda, Alain C Matagne, Patrice E Talaga, et al.
Journal of Medicinal Chemistry|August 2, 2012
Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)Pierre L Beaulieu, Michael Bös, Michael G Cordingley, et al.
Journal of Medicinal Chemistry|November 14, 2014
Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infectionPierre L Beaulieu, Paul C Anderson, Richard Bethell, et al.
Journal of Medicinal Chemistry|April 25, 2008
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonistsMaikel Wijtmans, Sylvain Celanire, Erwin Snip, et al.
Physical Review Letters|August 27, 2013
Precision measurement of charged pion and kaon differential cross sections in e+ e- annihilation at sqrt[s]=10.52  GeVM Leitgab, R Seidl, M Grosse Perdekamp, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|October 15, 2010
Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5BSteven R LaPlante, James R Gillard, Araz Jakalian, et al.
The American Journal of Physiology|March 10, 1999
Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidenceA M Khan, M C Currás, J Dao, et al.
Toxicology and Applied Pharmacology|August 9, 2011
Altered cardiovascular reactivity and osmoregulation during hyperosmotic stress in adult rats developmentally exposed to polybrominated diphenyl ethers (PBDEs)Ashini Shah, Cary G Coburn, Abena Watson-Siriboe, et al.
Endocrinology|November 12, 2005
A novel role for endogenous pituitary adenylate cyclase activating polypeptide in the magnocellular neuroendocrine systemE R Gillard, M León-Olea, S Mucio-Ramírez, et al.
Journal of Medicinal Chemistry|October 29, 2013
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127)Steven R LaPlante, Michael Bös, Christian Brochu, et al.
Journal of Medicinal Chemistry|January 23, 2004
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activityBenoit M Kenda, Alain C Matagne, Patrice E Talaga, et al.
Journal of Medicinal Chemistry|August 2, 2012
Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)Pierre L Beaulieu, Michael Bös, Michael G Cordingley, et al.
Journal of Medicinal Chemistry|November 14, 2014
Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infectionPierre L Beaulieu, Paul C Anderson, Richard Bethell, et al.
Journal of Medicinal Chemistry|April 25, 2008
4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonistsMaikel Wijtmans, Sylvain Celanire, Erwin Snip, et al.
Physical Review Letters|August 27, 2013
Precision measurement of charged pion and kaon differential cross sections in e+ e- annihilation at sqrt[s]=10.52  GeVM Leitgab, R Seidl, M Grosse Perdekamp, et al.
Pageof 6